Patents Assigned to Wellstat Ophthalmics Corporation
  • Vectors encoding rod-derived cone viability factor
    Patent number: 10040835
    Abstract: The present invention relates to nucleic acids coding for and capable of expressing a rod-derived cone viability factor (RdCVF) and viral vectors containing these nucleic acids. The invention also relates to compositions and pharmaceutical preparations comprising these nucleic acids or vectors, methods of producing or secreting an RdCVF, and methods of treatment.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: August 7, 2018
    Assignee: Wellstat Ophthalmics Corporation
    Inventor: Tianci Luo
  • Vectors encoding rod-derived cone viability factor
    Patent number: 9265813
    Abstract: The present invention relates to nucleic acids coding for and capable of expressing a rod-derived cone viability factor (RdCVF) and viral vectors containing these nucleic acids. The invention also relates to compositions and pharmaceutical preparations comprising these nucleic acids or vectors, methods of producing or secreting an RdCVF, and methods of treatment.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: February 23, 2016
    Assignee: Wellstat Ophthalmics Corporation
    Inventor: Tianci Luo
  • VECTORS ENCODING ROD-DERIVED CONE VIABILITY FACTOR
    Publication number: 20140328821
    Abstract: The present invention relates to nucleic acids coding for and capable of expressing a rod-derived cone viability factor (RdCVF) and viral vectors containing these nucleic acids. The invention also relates to compositions and pharmaceutical preparations comprising these nucleic acids or vectors, methods of producing or secreting an RdCVF, and methods of treatment.
    Type: Application
    Filed: October 26, 2012
    Publication date: November 6, 2014
    Applicant: Wellstat Ophthalmics Corporation
    Inventor: Tianci Luo